Intestinal immunization of mice with antigen conjugated to anti-MHC class II antibodies

By McDermott M.R.   Underdown B.J.   Snider D.P.   Estrada A.  

Vaccine, Vol. 13, Iss. 10, 1995-07 ,pp. : 901-907

Elsevier

Access to resources Recommend Favorite

The efficiency of antigen delivery from macrophage phagosomes into cytoplasm for MHC class I-restricted antigen presentation

By Oh Y.-K.   Harding C.V.   Swanson J.A.  

Vaccine, Vol. 15, Iss. 5, 1997-04 ,pp. : 511-518

Elsevier

Access to resources Recommend Favorite

Infection of mouse bone marrow-derived dendritic cells with recombinant adenovirus vectors leads to presentation of encoded antigen by both MHC class I and class II molecules-potential benefits in vaccine design

By Herrera O.B.   Brett S.   Lechler R.I.  

Vaccine, Vol. 21, Iss. 3, 2002-12 ,pp. : 231-242

Elsevier

Access to resources Recommend Favorite

MHC class I- and class II-restricted processing and presentation of microencapsulated antigens

By Men Y.   Audran R.   Thomasin C.   Eberl G.   Demotz S.   Merkle H.P.   Gander B.   Corradin G.  

Vaccine, Vol. 17, Iss. 9, 1999-03 ,pp. : 1047-1056

Elsevier

Access to resources Recommend Favorite

MHC class II engagement by its ligand LAG-3 (CD223) leads to a distinct pattern of chemokine and chemokine receptor expression by human dendritic cells

By Buisson S.   Triebel F.  

Vaccine, Vol. 21, Iss. 9, 2003-02 ,pp. : 862-868

Elsevier

Access to resources Recommend Favorite